{"title":"A bibliometric analysis of artificial intelligence research in critical illness: a quantitative approach and visualization study.","authors":"Zixin Luo, Jialian Lv, Kang Zou","doi":"10.3389/fmed.2025.1553970","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Critical illness medicine faces challenges such as high data complexity, large individual differences, and rapid changes in conditions. Artificial Intelligence (AI) technology, especially machine learning and deep learning, offers new possibilities for addressing these issues. By analyzing large amounts of patient data, AI can help identify diseases earlier, predict disease progression, and support clinical decision-making.</p><p><strong>Methods: </strong>In this study, scientific literature databases such as Web of Science were searched, and bibliometric methods along with visualization tools R-bibliometrix, VOSviewer 1.6.19, and CiteSpace 6.2.R4 were used to perform a visual analysis of the retrieved data.</p><p><strong>Results: </strong>This study analyzed 900 articles from 6,653 authors in 82 countries between 2005 and 2024. The United States is a major contributor in this field, with Harvard University having the highest betweenness centrality. Noseworthy PA is a core author in this field, and <i>Frontiers in Cardiovascular Medicine</i> and <i>Diagnostics</i> lead other journals in terms of the number of publications. Artificial Intelligence has tremendous potential in the identification and management of heart failure and sepsis.</p><p><strong>Conclusion: </strong>The application of AI in critical illness holds great potential, particularly in enhancing diagnostic accuracy, personalized treatment, and clinical decision support. However, to achieve widespread application of AI technology in clinical practice, challenges such as data privacy, model interpretability, and ethical issues need to be addressed. Future research should focus on the transparency, interpretability, and clinical validation of AI models to ensure their effectiveness and safety in critical illness.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1553970"},"PeriodicalIF":3.1000,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11914116/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1553970","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Critical illness medicine faces challenges such as high data complexity, large individual differences, and rapid changes in conditions. Artificial Intelligence (AI) technology, especially machine learning and deep learning, offers new possibilities for addressing these issues. By analyzing large amounts of patient data, AI can help identify diseases earlier, predict disease progression, and support clinical decision-making.
Methods: In this study, scientific literature databases such as Web of Science were searched, and bibliometric methods along with visualization tools R-bibliometrix, VOSviewer 1.6.19, and CiteSpace 6.2.R4 were used to perform a visual analysis of the retrieved data.
Results: This study analyzed 900 articles from 6,653 authors in 82 countries between 2005 and 2024. The United States is a major contributor in this field, with Harvard University having the highest betweenness centrality. Noseworthy PA is a core author in this field, and Frontiers in Cardiovascular Medicine and Diagnostics lead other journals in terms of the number of publications. Artificial Intelligence has tremendous potential in the identification and management of heart failure and sepsis.
Conclusion: The application of AI in critical illness holds great potential, particularly in enhancing diagnostic accuracy, personalized treatment, and clinical decision support. However, to achieve widespread application of AI technology in clinical practice, challenges such as data privacy, model interpretability, and ethical issues need to be addressed. Future research should focus on the transparency, interpretability, and clinical validation of AI models to ensure their effectiveness and safety in critical illness.
背景:危重疾病医学面临数据复杂性高、个体差异大、病情变化快等挑战。人工智能(AI)技术,特别是机器学习和深度学习,为解决这些问题提供了新的可能性。通过分析大量患者数据,人工智能可以帮助更早地识别疾病,预测疾病进展,并支持临床决策。方法:检索Web of Science等科学文献数据库,利用R-bibliometrix、VOSviewer 1.6.19、CiteSpace 6.2等可视化工具进行文献计量学分析。R4用于对检索到的数据进行可视化分析。结果:这项研究分析了2005年至2024年间82个国家6653位作者的900篇文章。美国是这一领域的主要贡献者,哈佛大学的中间性中心性最高。Noseworthy PA是该领域的核心作者,《Frontiers in Cardiovascular Medicine and Diagnostics》在发表论文数量上领先于其他期刊。人工智能在识别和治疗心力衰竭和败血症方面具有巨大的潜力。结论:人工智能在危重疾病中的应用具有很大的潜力,特别是在提高诊断准确性、个性化治疗和临床决策支持方面。然而,要实现人工智能技术在临床实践中的广泛应用,需要解决数据隐私、模型可解释性和伦理问题等挑战。未来的研究应侧重于人工智能模型的透明度、可解释性和临床验证,以确保其在危重疾病中的有效性和安全性。
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world